RACHEL MAGLOIRE: Open Payments
NPI 1285709055 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 24 payments from 12 companies in 2025. Trend: 2023 $3,271 · 2024 $2,493 · 2025 $747
Food & beverage: $598Education: $149
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $192 |
| Merck Sharp & Dohme LLC | 2 | $150 |
| Astellas Pharma US Inc | 3 | $100 |
| SEAGEN INC. | 1 | $99 |
| Gilead Sciences, Inc. | 2 | $43 |
| Lilly USA, LLC | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Celgene Corporation | 1 | $21 |
Products named: KEYTRUDA, ELREXFIO, Vyloy, Trodelvy, IBRANCE, BOSULIF, VERZENIO, OPDIVO.
Industry payments across NY — which companies pay providers there.
